Global Proteomics Market

Proteomics Market Size, Share, Growth Analysis, By Equipment(Chromatography, Mass Spectroscopy and Protein Microarray), By Services(Laboratory Services, Data Analysis & Services and Others), By Application(Drug Discovery and Clinical Diagnosis), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2281 | Region: Global | Published Date: August, 2024
Pages: 157 | Tables: 94 | Figures: 76

Proteomics Market News

 

  • In August 2024, With the release of the Orbitrap Exploris 240 mass spectrometer from Thermo Fisher Scientific, proteome analysis has been improved with increased sensitivity and resolution. By enhancing protein identification and quantification, this novel method facilitates cutting-edge research and practical applications. Thermo Fisher's dedication to developing proteomics technologies is evident in this launch.  
  • In July 2024, The triple quad mass spectrometer 6495B is new from Agilent Technologies and is intended for high-throughput proteomics applications. This advanced tool allows a more sensitive and quicker protein analysis, resulting in more exact and exhaustive outcomes. Agilent's advancement is expected to improve research capacities and optimize proteomic workflows across multiple scientific domains. 
  • In June 2024, the innovative timsTOF Pro 2 mass spectrometer with ion mobility spectrometry has been launched by the Bruker Corporation. This innovation provides improved protein separation and characterization, thus enabling in-depth proteomic studies. Bruker’s latest offer aims at improving analytical performance while opening up new avenues for proteomics research. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Proteomics Market size was valued at USD 25.2 Billion in 2022 poised to grow from USD 29.35 Billion in 2023 to USD 100.17 Billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031). 

In the global proteomics market, competition was fierce, and leading companies leveraged state-of-the-art technology as well as strategic partnerships. Innovators include Thermo Fisher Scientific - a leader in mass spectrometry; Agilent Technologies who provides chromatographic and spectroscopic instruments for various applications and SCIEX - known for its high-performance analytical systems. These businesses portray themselves as leaders in developing proteomics research and applications globally by ongoing R&D, product advancements, and strategic acquisitions.  'Thermo Fisher Scientific (USA) ', 'Agilent Technologies (USA) ', 'SCIEX (USA) ', 'Waters Corporation (USA) ', 'Bruker Corporation (Germany) ', 'Danaher Corporation (USA) ', 'PerkinElmer, Inc. (USA) ', 'GE Healthcare Life Sciences (UK) ', 'Bio-Rad Laboratories (USA) ', 'Luminex Corporation (USA) ', 'Shinwa Chemical Industries (Japan) ', 'Nexelis (Canada) ', 'Proteome Sciences (UK) ', 'Molecular Devices (USA) ', 'Kyowa Kirin (Japan) '

Technological developments that have significantly increased sensitivity and resolution, enabled high-throughput and multiplexed analysis, facilitated data integration, and better sample preparation and fractionation techniques have revolutionized the discipline of proteomics. Proteome has become more fully understood due to these breakthroughs, which have been crucial in propelling the market's growth. 

Technological Advances in Mass Spectrometry and Sequencing: Due to developments in technology like mass spectrometry and next-generation sequencing, the global proteomics market has witnessed a lot of growth in a short time. Biological processes’ intricacy has been brought to light through advances in sensitivity and accuracy of protein evaluations, enabling researchers to have a better understanding. Proteomics is an indispensable part of biomarker discovery in that it helps to identify precise proteins related to diseases. 

North America has a dominant share in the global proteomics market due to its strong research infrastructure, large investments in pharmaceuticals and biotechnology, and sophisticated technological capabilities. High levels of financing from the public and commercial sectors enable state-of-the-art proteomic research, which is fuelled by the region's robust academic and research institutions. Furthermore, the regulatory environment and well-established healthcare system in North America support the quick uptake of novel proteomic technologies in drug discovery and clinical settings. Owing to strong support by influential players in the industry and a collaboration-based system, the region leads the global proteomics market and further advances and develops. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Proteomics Market

Report ID: SQMIG35G2281

$5,300
BUY NOW GET FREE SAMPLE